Moreover, ablation or inhibition of Oct-4 hinders proliferation and augments chemotherapy efficacy in cancer stem-like cells (Chen et al., 2008; Hu et al., 2008; Yun et al., 2015). This evidence concerns the gene POU5F1 and cancer.